Cephalon

TRUXIMA

View Prices
  1. Home
    2.  / 
  2. Q Code
    3.  / TRUXIMA – Q5115

Manufacturer:

Cephalon

Name:

TRUXIMA

HCPCS Code Descriptor:

Injection, rituximab-abbs, biosimilar, (truxima), 10 mg

Category:

Q Code

HCPCS:

Q5115

NDC(s):

63459-0103-10, 63459-0104-50

Primary Type:

Oncology Biosimilar

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

TRUXIMA is an Oncology Biosimilar drug manufactured by Cephalon and administered via the Intravenous route of administration. The Q Code: Q5115 is aligned to the drug TRUXIMA.

Truxima is used to treat certain types of cancer, joint pain, certain blood vessel diseases, and a certain skin condition. Truxima works by slowing down or stopping the growth of certain cells, which can be cancer-causing. Truxima is a branded drug manufactured by Cephalon and is a biosimilar to the reference product Rituxan (J9312). Patient assistance programs for this medication can be found through Teva pharmaceuticals.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/19

HCPCS Effective Date:

7/1/19

HCPCS Short Description:

Inj truxima 10 mg

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.truximahcp.com/support-resources